Evaluation of new drugs in untreated patients with small-cell lung cancer: its time has come

Affiliations

Comment

D S Ettinger. J Clin Oncol. 1990 Mar.

. 1990 Mar;8(3):374-7.

doi: 10.1200/JCO.1990.8.3.374.

No abstract available

Comment on

Epirubicin in extensive small-cell lung cancer: a phase II study in previously untreated patients: a National Cancer Institute of Canada Clinical Trials Group Study.
Blackstein M, Eisenhauer EA, Wierzbicki R, Yoshida S. Blackstein M, et al. J Clin Oncol. 1990 Mar;8(3):385-9. doi: 10.1200/JCO.1990.8.3.385. J Clin Oncol. 1990. PMID: 2155308 Clinical Trial.
Phase II study of amonafide: results of treatment and lessons learned from the study of an investigational agent in previously untreated patients with extensive small-cell lung cancer.
Evans WK, Eisenhauer EA, Cormier Y, Ayoub J, Wierzbicki R, Laberge F, Shepherd FA. Evans WK, et al. J Clin Oncol. 1990 Mar;8(3):390-5. doi: 10.1200/JCO.1990.8.3.390. J Clin Oncol. 1990. PMID: 2155309